238 related articles for article (PubMed ID: 2574209)
21. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
22. [Clinical usefulness of serum sialyl Le(x)-i measurement in patients with ovarian cancer].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):15-9. PubMed ID: 2564410
[TBL] [Abstract][Full Text] [Related]
23. [Clinical value of a new serum tumor marker CA602 in ovarian cancers].
Suzuki M; Sekiguchi I; Ohwada M; Aida I; Tamada T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1454-60. PubMed ID: 2170549
[TBL] [Abstract][Full Text] [Related]
24. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
25. [Tumor markers of ovarian cancer].
Nozawa S
Rinsho Byori; 1992 Apr; 40(4):349-53. PubMed ID: 1593759
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
[TBL] [Abstract][Full Text] [Related]
27. [The significance of CA-50, SLX and ST-439 in lung cancer].
Hayasaka S; Takada M; Shinohara T; Imamura S; Takifuji N; Kudoh S; Matsui K; Kusunoki Y; Masuda N; Negoro S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):802-7. PubMed ID: 1681128
[TBL] [Abstract][Full Text] [Related]
28. [Sialyl Lewis(x)-I (SLX) as a tumor-associated carbohydrate antigen in sera in patients with gastric and colorectal cancer--evaluation according to clinico-pathological factors].
Nakagoe T; Ishikawa H; Nakao H; Satoh T; Miyashita K; Yokota M; Takahira R; Kusano H; Shimizu T; Fukuda Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):819-25. PubMed ID: 2565704
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of ovarian tumors by transvaginal color-pulse Doppler sonography.
Kawai M; Kikkawa F; Ishikawa H; Tamakoshi K; Maeda O; Hasegawa N; Mizuno K; Suzuki A; Itakura A; Nakashima N
Gynecol Oncol; 1994 Aug; 54(2):209-14. PubMed ID: 8063248
[TBL] [Abstract][Full Text] [Related]
30. Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer--a study on 674 patients.
Takahashi K; Shibukawa T; Moriyama M; Shirai T; Kijima S; Iwanari O; Matsunaga I; Kitao M
Jpn J Surg; 1986 Sep; 16(5):305-10. PubMed ID: 3467109
[TBL] [Abstract][Full Text] [Related]
31. [The present and the future of tumor markers].
Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):883-9. PubMed ID: 1680941
[TBL] [Abstract][Full Text] [Related]
32. The role of CA 125 and conventional examinations in diagnosing progressive carcinoma of the ovary.
van der Burg ME; Lammes FB; Verweij J
Surg Gynecol Obstet; 1993 Apr; 176(4):310-4. PubMed ID: 8460404
[TBL] [Abstract][Full Text] [Related]
33. [Field trial for the early detection of patients with ovarian cancer].
Kobayashi H; Terao T
Rinsho Byori; 1992 Feb; 40(2):139-45. PubMed ID: 1374818
[TBL] [Abstract][Full Text] [Related]
34. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
35. [The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes].
Nozawa S; Yajima M; Udagawa Y; Kiguchi K; Iizuka R; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1823-9. PubMed ID: 2687409
[TBL] [Abstract][Full Text] [Related]
36. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
[TBL] [Abstract][Full Text] [Related]
37. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
Kikuchi Y; Hisano A; Kuki E; Hirata J; Nagata I
Gynecol Obstet Invest; 1991; 31(3):161-5. PubMed ID: 2071055
[TBL] [Abstract][Full Text] [Related]
38. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O
Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707
[TBL] [Abstract][Full Text] [Related]
39. CA54/61 as a marker for epithelial ovarian cancer.
Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
[TBL] [Abstract][Full Text] [Related]
40. Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer.
Kudlacek S; Schieder K; Kölbl H; Neunteufel W; Nowotny C; Breitenecker G; Biegelmayer G; Vetterlein M; Fürlinger B; Micksche M
Gynecol Oncol; 1989 Dec; 35(3):323-9. PubMed ID: 2480931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
